The RNA modification N6-methyladenosine (m 6 A) can modulate mRNA fate and thus 36 affect many biological processes. We analyzed m 6 A modification across the transcriptome 37 following infection by dengue virus (DENV), Zika virus (ZIKV), West Nile virus (WNV), and 38 hepatitis C virus (HCV). We found that infection by these viruses in the Flaviviridae family alters 39 m 6 A modification of specific cellular transcripts, including RIOK3 and CIRBP. During viral 40 infection, the addition of m 6 A to RIOK3 promotes its translation, while loss of m 6 A in CIRBP 41 promotes alternative splicing. Importantly, we found that activation of innate immune sensing or 42 the endoplasmic reticulum (ER) stress response by viral infection contributes to the changes in 43 m 6 A modification in RIOK3 and CIRBP, respectively. Further, several transcripts with infection-44 altered m 6 A profiles, including RIOK3 and CIRBP, encode proteins that influence DENV, ZIKV, 45 and HCV infection. Overall, this work reveals that cellular signaling pathways activated during 46 viral infection lead to alterations in m 6 A modification of host mRNAs to regulate infection. 47 48 Introduction 49
Summary 35
The RNA modification N6-methyladenosine (m 6 A) can modulate mRNA fate and thus 36 affect many biological processes. We analyzed m 6 A modification across the transcriptome 37 following infection by dengue virus (DENV), Zika virus (ZIKV), West Nile virus (WNV), and 38 hepatitis C virus (HCV). We found that infection by these viruses in the whereby the host attempts to resist infection by up-or down-regulating relevant genes while 58 viruses co-opt host transcription to facilitate replication and avoid host defenses (Fink et al., 2007; 59 m 6 A antibody to enrich m 6 A-modified RNA fragments prior to RNA sequencing of both the input 115 and immunoprecipitated (IP) fractions (Dominissini et al., 2012; Meyer et al., 2012) . We note that 116 this antibody can also recognize the similar modification N6,2'-O-dimethyladenosine (m 6 Am), 117 which is found at lower abundance than m 6 A and, in mRNA, only within the 5' cap (Linder et al., 118 2015; Mauer and Jaffrey, 2018) . We performed MeRIP-seq on RNA extracted from human Huh7 119 liver hepatoma cells, which are permissive for infection by all four viruses. At 48 hours post-120 infection, 60-90% of cells were infected with DENV, ZIKV, WNV, or HCV, depending on the virus 121 ( Figure S1A ). We first identified the gene expression changes in response to infection. To do this, 122 we analyzed differential expression of genes between infected samples and uninfected controls 123 using the input fractions from MeRIP-seq and found 50 genes that were significantly differentially 124 expressed (DESeq2, adjusted p < 0.05, |Log2Fold Change (FC)| ≥ 2) following infection by all four 125 viruses individually (Figure S1B-C, Table S1 ). Notably, although ZIKV, DENV, and WNV are 126 known to generate acute, cytotoxic responses, while HCV leads to persistent infection (Neufeldt 127 et al., 2018) , we found that several pathways were similarly altered by all of these viruses in Huh7 128 cells. Significantly upregulated pathways included those associated with innate immunity (such 129 as NF-κB, TNF, and MAPK signaling) and the ER stress response, while downregulated pathways 130 included those associated with the cell cycle ( Figure S1D ). These results, which we validated by 131 We then predicted m 6 A-modified regions by calling peaks in IP over input RNA-seq 157 coverage across transcripts using MACS2 (Zhang et al., 2008) . We detected a total of 31,647 158 peaks, with 25,852 exonic peaks corresponding to 10,891 genes across all uninfected and 159 infected samples ( Figure 1B) . The known m 6 A motif DRACH (in particular, GGACU), was enriched 160 under the identified peaks ( Figure 1C ). As expected, detected peaks were most common at the 161 end of the coding sequence and beginning of the 3' untranslated region (UTR) ( Figure 1D 1D). This is in contrast to a previous report that suggested ZIKV infection was associated with 165 increased methylation at the 5' UTRs of cellular transcripts (Lichinchi et al., 2016b) ; however, we 166 also did not detect a difference in m 6 A distribution following ZIKV infection on reanalysis of that 167 published data ( Figure S1F ). Further, following viral infection, we found only subtle changes in 168 the overall level of m 6 A relative to unmodified adenosine in purified mRNA, as analyzed by liquid 169 chromatography tandem-mass spectrometry (LC-MS/MS) of digested nucleotides, and no change 170 in the expression of cellular m 6 A machinery, as analyzed by immunoblotting ( Figure S1G -H). 171
Indeed, since the expression of the methylation machinery was not changed by infection, we 172 would not predict broad, unidirectional changes in the abundance or distribution of m 6 A on cellular 173
transcripts. 174
However, functional annotation of the m 6 A-modified genes expressed in the infected 175 samples did reveal an enrichment for genes with roles in infection. In total, 829 methylated genes 176 were annotated as involved in the Reactome Pathways of "Infectious Disease", "Unfolded Protein 177
Response", "Interferon Signaling", or "Innate Immune System" ("Infection-annotated genes"; see 178
Methods; Figure 1B) . Further, 345 genes that were differentially expressed between infected and 179 uninfected samples were also methylated ("Infection-regulated genes"; Figure 1B ). Indeed, 180 mRNAs that changed expression with infection (p adj < 0.05, |Log2FC| ≥ 2, mean expression ≥ 181 50) were more likely to have at least one m 6 A site than those that did not change expression (p 182 adj > 0.05, |Log2FC| < 0.5, mean expression ≥ 50; Fisher's exact test p = 0.00074, odds ratio = 183 0.64) ( Figure 1E ). These results are consistent with previous reports that genes that undergo 184 dynamic regulation tend to contain more m 6 A sites in their transcripts than stable housekeeping 185 genes (Schwartz et al., 2014) , and suggest that m 6 A may be an important regulator of genes 186 implicated in infection. 187
We next predicted changes in m 6 A based on differences in IP enrichment relative to gene 188 expression with infection by all four Flaviviridae members. We detected shared m 6 A changes in 189 58 exonic peaks in 51 genes following infection with all viruses, most of which showed increases 190 in m 6 A and occurred within the 3' UTR or coding sequence of the transcript ( Figure 1B , Table S2 ). 191
Whereas genes that showed changes in expression were enriched for pathways with known roles 192 in infection ( Figure S1D ), genes that showed changes in methylation did not show any enrichment 193 for functional categories relevant to infection. We and others previously showed that MeRIP- qPCR can detect relative changes in m 6 A levels (Engel et al., 2018; McIntyre et al., 2019) . 195
Therefore, we used this method with RT-qPCR primers under the changed m 6 A peaks to 196 orthogonally validate a set of 18 of the predicted m 6 A changes in transcripts following infection. 197
In these and subsequent analyses, we focused on m 6 A changes following infection by DENV, 198 ZIKV, and HCV. Of the 18 transcripts tested by MeRIP-RT-qPCR, 16 showed a significant change 199 in m 6 A modification relative to any change in gene expression with at least two viruses, and 9 of 200 those showed a significant change with all three viruses. The control mRNAs (ACTB and MAVS), 201 both predicted to be stably methylated during infection, indeed showed no m 6 we also wanted to detect any peak changes unique to single viruses, and therefore, we used the 207 same computational approach described above to identify significant peaks unique to each virus 208 (Table S2 ). MeRIP-RT-qPCR validation of these putative virus-specific peaks (two per virus) 209 showed similar changes in relative m 6 A modification at those peaks with infection by all three 210 viruses tested, rather than individual virus-mediated changes ( Figure S1I ), suggesting that most 211 m 6 A regulation occurs through processes activated in response to infection by all the Flaviviridae 212 we tested. Together, our data reveal that hundreds of transcripts differentially expressed during 213
Flaviviridae infection contain m 6 A and that infection alters m 6 A modification of specific host 214
transcripts. 215 216
Flaviviridae infection alters m 6 A modification of RIOK3 and CIRBP mRNA through distinct 217
pathways. 218
We focused on two specific transcripts that gain or lose m 6 A during infection by all viruses 219 (DENV, ZIKV, WNV, and HCV) for further analysis: RIOK3 (gains) and CIRBP (loses). RIOK3 220 encodes a serine/threonine kinase and has been implicated in regulating antiviral signaling (Feng 221 et al., 2014; Takashima et al., 2015; Willemsen et al., 2017) , while CIRBP encodes a stress-222 induced RNA-binding protein (Liao et al., 2017) . Following viral infection, RIOK3 mRNA gains an 223 m 6 A peak in the 3' UTR close to the stop codon ( Figure 2A ), and CIRBP mRNA shows reduced 224 m 6 A modification in the coding sequence of its last exon ( Figure 2B ). The RIOK3 and CIRBP 225 peaks span four and three DRACH motifs, respectively. Both peaks have been previously 226 reported in published datasets, although the function of m 6 A on these transcripts has not been 227 investigated; the RIOK3 peak was identified in mouse liver tissue (Zhou et al., 2018) MeRIP-RT-qPCR on RNA from cells infected with DENV, ZIKV, and HCV to validate these 230 predicted changes in m 6 A, as in Figure 1F . MeRIP-RT-qPCR confirmed that relative to gene 231 expression, the m 6 A modification of RIOK3 significantly increased following infection and that of 232 CIRBP decreased, while RIOK3 and CIRBP mRNA levels both increased following infection 233 ( Figure 1F Fredericksen, 2010; Suthar et al., 2013 ). Therefore, we tested whether innate immune activation 246 in the absence of a replicating virus alters m 6 A modification. We measured the relative m 6 A levels 247 of RIOK3 and CIRBP mRNA by MeRIP-RT-qPCR following transfection of Huh7 cells with the 248 short, previously described, HCV pathogen-associated molecular pattern (HCV PAMP) 249 immunostimulatory RNA (Saito et al., 2008) . As expected, HCV PAMP induced expression of 250 IFNB1 and the ISG IFIT1 ( Figure 2D ). It also increased m 6 A modification of RIOK3 mRNA to a 251 similar degree as viral infection, but it did not reproduce the decrease in CIRBP methylation seen 252 with viral infection ( Figure 2D ). These data indicate that innate immune signaling promotes the 253 m 6 A modification of RIOK3 mRNA following infection. 254 S3B). However, we did detect increased nascent translation of RIOK3 in DENV-infected cells 292 compared to uninfected cells as measured by 35 S labeling of nascent proteins followed by RIOK3 293 protein immunoprecipitation, suggesting that RIOK3 translation was increased in infected cells 294 ( Figure 3B ). This is consistent with our observation that during infection RIOK3 has increased 295 binding to the m 6 A reader protein YTHDF1, which is known to promote translation of bound 296 mRNAs under specific conditions ( Figure S2D To directly test whether m 6 A can promote RIOK3 protein expression during infection, we 321 generated Huh7 cell lines stably expressing a luciferase reporter which contains the wild type 322 (WT) RIOK3 3' UTR, or an analogous 3' UTR sequence in which all putative m 6 A sites were 323 abrogated by A®T mutations (m 6 A-mut), downstream of a Renilla luciferase gene in which all 324 DRACH motifs were ablated (m 6 A-null) ( Figure 3C ). These constructs also expressed a separate 325 m 6 A-null Firefly luciferase gene whose expression is not regulated by m 6 A. As expected, the WT 326 RIOK3 reporter had increased m 6 A modification compared to the m 6 A-mut RIOK3 reporter 327 following viral infection, as measured by MeRIP-RT-qPCR using primers that specifically amplified 328 reporter RNA ( Figure 3D ). This reveals that the RIOK3 3' UTR sequence is sufficient for m 6 A 329 addition following infection. Importantly, the relative luciferase activity of the WT RIOK3 reporter 330 was significantly increased compared to the m 6 A-mut reporter following viral infection ( Figure 3E ). 331
Taken together, these data reveal that m 6 A modification of the 3' UTR of RIOK3 mRNA during 332 infection consistently promotes its translation during infection with all three Flaviviridae tested. 333 334 m 6 A modification promotes alternative splicing of CIRBP mRNA during infection 335
We then analyzed the function of reduced m 6 A modification in CIRBP mRNA following 336 infection. Neither the nuclear export nor the stability of CIRBP mRNA were consistently affected 337 following DENV, ZIKV, or HCV infection, suggesting that the loss m 6 A in CIRBP does not regulate 338 these processes ( Figure S4A -B). Based on our RNA-seq data, CIRBP encodes at least 2 339 isoforms: (1) the dominant, short isoform (CIRBP-S) which encodes a 172 aa, 18 kDa protein and 340
(2) a second, long isoform in which an intron immediately downstream of the infection-altered m 6 A 341 peak and upstream of the stop codon is retained (CIRBP-L), resulting in a 297 aa, 32 kDa protein 342 ( Figure 4A ; retained intron referred to as alternatively spliced region (ASR)). Interestingly, analysis 343 of our RNA-seq data using MAJIQ (Vaquero-Garcia et al., 2016) to identify local splice variants 344 suggested decreased retention of this intron during infection, which we confirmed in DENV, ZIKV, 345 and HCV-infected cells using RT-qPCR ( Figure 4B ). We observed a similar reduction of intron 346 retention following thapsigargin treatment, which we had found also reduces m 6 A modification of 347 CIRBP ( Figure 4C and 2F). Indeed, both viral infection and thapsigargin treatment significantly 348 reduced the protein level of CIRBP-L containing the retained intron, while not affecting expression 349 of CIRBP-S ( Figure 4D -E). To test whether reduction of m 6 A modification at the m 6 A peak in 350 CIRBP might affect alternative splicing of this transcript, we generated a splicing reporter wherein 351 the m 6 A-null Renilla luciferase gene was fused to the WT genomic sequence of CIRBP from exon 352 5 onwards (WT CIRBP) and a corresponding reporter in which the putative m 6 A sites in the 353 identified CIRBP m 6 A peak were synonymously mutated (m 6 A-mut CIRBP) ( Figure 4F ). Using 354 RT-qPCR, we found that the m 6 A-mut reporter had reduced intron retention compared to the WT 355
reporter, suggesting that the loss of m 6 A in CIRBP regulates its alternative splicing and reduces 356 the expression of the long isoform ( Figure 4G ). 357 Having found that both RIOK3 and CIRBP transcripts have altered m 6 A modification during 377 infection, we next tested whether their encoded protein products affect Flaviviridae infection. To 378 this end, we depleted RIOK3 and CIRBP in Huh7 cells using small interfering RNA (siRNA), 379 infected these cells with DENV, ZIKV, or HCV, and then measured viral titer in the supernatant at 380 72 hours post-infection. siRNA treatment reduced both RIOK3 and CIRBP mRNA levels by ~70% 381 and did not affect cell viability ( Figure S5A ). We found that RIOK3 depletion significantly reduced 382 the production of infectious DENV and ZIKV particles but increased the production of infectious 383 HCV particles ( Figure 5A ). Consistent with these data, RIOK3 stably overexpressed in two 384 different clonal cell lines (RIOK3-1 and RIOK3-2) had the opposite effect on DENV, ZIKV, and 385 HCV infectious particle production ( Figure 5B -C). This suggests that RIOK3 promotes DENV and 386 ZIKV infection but inhibits HCV infection. In contrast, the depletion of CIRBP consistently reduced 387 the production of infectious DENV, ZIKV, and HCV ( Figure 5D ), while overexpression of both the 388 short and long isoforms of CIRBP in two different clonal cell lines (CIRBP-S-1 and 2, CIRBP-L-1 389
and 2) increased infection by these viruses (Figure 5E -F). 390
We then performed a targeted siRNA screen to test whether other transcripts with 391 infection-altered m 6 A modification affect Flaviviridae infection. We depleted transcripts in which 392 we had identified m 6 A changes during infection (either co-regulated ( Figure 1F ) or virus-specific 393 ( Figure S1I) ), infected depleted cells with DENV, ZIKV, or HCV, and measured cell viability, 394 relative RNA depletion levels, and the production of infectious virions in the supernatant at 48 395 hours post-infection ( Figure 5G and S5A-B). We focused only on those transcripts that were 396 depleted by at least 40% in our further analysis (21 out of 24 tested). For these, we found that 397 86% (18/21) regulate at least 1 virus, while 10/21 affect at least 2, and 6/21 regulate all three 398 viruses. For each virus, ~50% of m 6 A-altered transcripts that we tested significantly increased or 399 decreased infection. This indicates that by modifying specific transcripts that modulate infection, 400 m 6 A can tune the outcome of infection. 401 Here, we identify changes in m 6 A methylation of cellular mRNAs during infection by 420 viruses in the Flaviviridae family, specifically DENV, ZIKV, WNV, and HCV. We observed that 421 infection by all of these viruses leads to changes in m 6 A modification of a specific set of cellular 422 transcripts, including some that encode factors that modulate Flaviviridae infection in Huh7 cells. 423
We found that virus-induced pathways, including innate immune signaling and ER stress 424 responses, contributed to altered m 6 A modification of at least two of these transcripts during 425 infection. Taken together, this work suggests that m 6 A epitranscriptomic changes induced through 426 cellular signaling pathways influence Flaviviridae infection. 427
We identified hundreds of m 6 A-modified transcripts that were differentially expressed 428 during infection or that were annotated as part of cellular pathways relevant for infection. These 429 findings suggest that m 6 A has the potential to post-transcriptionally regulate many genes during 430 infection. Here, we focused on specific transcripts with virus-induced m 6 A changes; we identified 431 virus, approximately half of the factors that we tested that were efficiently depleted showed either 519 proviral or antiviral effects, while in total 86% had roles on any virus. These data suggest that m 6 A 520 itself does not represent a proviral or antiviral mechanism during infection, but rather modulates 521 transcripts that ultimately affect the outcome of infection by different members of the Flaviviridae ≥ 2 and adjusted p-value < 0.05 with all viruses were considered. There were very few consistently 640 downregulated genes at Log2FC ≤ -2 (particularly for ZIKV), so we expanded our set to genes 641 with smaller Log2FC ≤ -0.5, downregulated by DENV, HCV, and WNV infection. For REVIGO, we 642 allowed similarity of up to 0.5, with semantic similarity calculated using SimRel. Adjusted p-values 643 were provided for the REVIGO calculations. Gene set enrichment analyses using fgsea in R 644 showed similar differentially regulated pathways as gProfiler (Sergushichev, 2016) . "Infection-645 annotated" genes and peaks were summarized for Figure 1B based on gene inclusion in 646 "Infectious disease", "Unfolded Protein Response (UPR)", "Interferon Signaling", and "Innate 647
Immune System" Reactome pathways from fgsea. 648
We called m 6 A peaks from MeRIP-seq using MACS2 (Zhang et al., 2008) and used all 649 peaks detected in at least two replicates for further analysis. Motif enrichment was calculated 650 using HOMER for Figure 1C transcribed with the Superscript III enzyme (Invitrogen) using a gene specific primer. RT-qPCR 676 was performed using specific primers that detect CIRBP isoforms. The expression of each isoform 677 was normalized to invariant region of CIRBP. Primer sequences are provided in Table S3 . 678 in 2X Laemmli sample buffer (Bio-Rad). RNA was extracted from ninety percent of beads using 713 TRIzol reagent (Thermo Fisher). Equal volumes of eluted RNA were used for cDNA synthesis, 714 quantified by RT-qPCR, and normalized to RNA levels in input samples. Fold enrichment was 715 calculated with FLAG-GFP and mock samples set as 1. 716 siRNA treatment and viral infectivity assays. Cells seeded in 24-well plates were transfected 717 with siRNA against intended targets (Qiagen, sequences provided in Table S3) Table S3 ). Cellular viability after siRNA treatment was measured by the 731 Cell-Titer Glo assay (Promega) according to the manufacturer's recommendation. 732 Table S3 . RIOK3 (NM_003831.4) and both long (NM_001300829) and 774 short (NM_001280) isoforms of CIRBP were cloned by PCR (HiFi PCR premix, Clontech) from 775 cDNA from Huh7 cells prepared with the Superscript III RT kit (Thermo Fisher) using the 776 oligo(dT)20 primer. PCR products were inserted into pLEX-FLAG lentiviral vector between the NotI 777 and XhoI sites using the InFusion HD cloning kit (Takara Bio) to generate constructs with N-778 terminal FLAG tags. Lentivirus was produced from 293T cells transfected with pLEX vectors and 779 packaging plasmids psPAX2 and pMD2.G (provided by Duke Functional Genomics Facility). 780 Huh7 cells were transduced by these lentiviruses and stable cell lines expressing FLAG-RIOK3, 781 FLAG-CIRBP-S, and FLAG-CIRBP-L were selected using puromycin (2 µg/mL). Single cell clones 782 were obtained by serial dilution and verified by immunoblotting. Cell lines were maintained in 783 cDMEM containing 1 µg/mL puromycin. 784
785
Reporter cloning and luciferase assays. All primer and gBlock sequences are provided in Table  786 S3. To generate m 6 A-null RIOK3 reporters, the Renilla and Firefly luciferase genes in psiCheck2 787 plasmid (Promega) were first replaced by constructs with synonymous mutations in putative m 6 A 788 sites (obtained as IDT gBlocks). The wild type RIOK3 3' UTR was cloned from Huh7 cDNA 789 (NM_003831.4) and inserted after the m 6 A-null Renilla luciferase gene in the multiple cloning site 790 of psiCheck2 between XhoI and NotI using the InFusion HD kit. m 6 A-mut RIOK3 3' UTR (in which 791 all putative m 6 A sites were mutated from A to T) was obtained as a gBlock and also inserted 792 between these restriction sites. WT and m 6 A-mut RIOK3 reporter plasmids along with the pcDNA-793
Blast plasmid (Kennedy et al., 2015) were linearized using BamHI and BglII respectively, purified 794 by ethanol precipitation and co-transfected into Huh7 cells in 6-well plates (90 ng reporter, 10 ng 795 pcDNA-Blast) using FuGENE 6 transfection reagent (Promega). Cells were selected with 796 blasticidin (0.2 μg/mL) and single cell clones stably expressing WT and m 6 A-mut reporters were 797 isolated. For MeRIP-RT-qPCR of reporter RNA, WT and m 6 A-mut expressing cells were plated in 798 6-well plates, infected with the indicated virus (MOI 1), and RNA was extracted using TRIzol at 799 48 hours post-infection. Following MeRIP as described, RT-qPCR was performed to discriminate 800 reporter RNA using a forward primer within the Renilla luciferase gene and a reverse primer in 801 the RIOK3 3' UTR. For luciferase assays, WT and m 6 A-mut expressing cells in 24-well plates 802 were infected with the indicated virus (MOI 1) and dual luciferase assay (Promega) was performed 803 at 48 hours post-infection according to the manufacturer's instructions. Data was normalized as 804 the value of Renilla luminescence divided by Firefly luminescence, and values for mock-infected 805 cells were set as 1. 806
To generate CIRBP splicing reporters, CIRBP exon 5 -3' UTR (Hg38;chr19:127553-807 1273172) was amplified by PCR from genomic DNA. A fragment of m 6 A-null Renilla luciferase 808 beyond the NruI site and up to the stop codon was amplified by PCR with overlapping ends with 809
Renilla luciferase (5'; before the NruI site) and the CIRBP fragment (3'). These fragments were 810 inserted into NruI-XhoI digested psiCheck2 m 6 A-null plasmid using the InFusion HD kit. m 6 A-mut 811 CIRBP reporter was generated by mutating the essential C in the m 6 A site synonymously to T 812 using two rounds of site-directed mutagenesis with the QuikChange Lightning kit (Agilent). 813 814 35 S labeled immunoprecipitation for nascent translation. Huh7 cells seeded in 10 cm plates 815 were infected with DENV (MOI 1) or left uninfected. At 45 hours post-infection, media was 816 removed and 3 mL warm methionine/cysteine-free DMEM was added to plates. After 15 minutes 817 of incubation, 3 mL methione/cysteine-free DMEM containing 100 mCi 35 S (Perkin Elmer) was 818 added. Cells were harvested at 3 hours post-treatment and lysed in RIPA buffer. 300 µg protein 819 was incubated with 4 µg anti-RIOK3 antibody (Proteintech) or normal rabbit IgG (Cell Signaling) 820 in 300 µL RIPA buffer overnight at 4°C with rotation. Antibody-protein complexes were then 821 incubated with 40 µL pre-washed protein G Dynabeads (Thermo Fisher) for 2 hours. Protein was 822 eluted from beads in 2X Laemmli buffer. Eluates were resolved by SDS/PAGE. Gels were fixed 823 in solution containing 50% methanol and 10% acetic acid, dried, and subjected to autoradiography 824 on film. 
